@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "additional treatment" . rdf:OBJECT-POSITION rdfs:label "(19, 27)" . rdf:PREDICATE rdfs:label "received" . rdf:SUBJECT rdfs:label "patients" . rdf:SUBJECT-POSITION rdfs:label "(19, 27)" . ns1:receive ; rdfs:label "patients" . rdfs:label "treatment" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-12T10:38:41.130861"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377 . rdf:Statement rdfs:label "34 out of 68 (50%) patients in the standard treatment group and 7 out of 90 (7.7%) in a cohort of patients who received additional treatment with tocilizumab once (either 400 mg intravenous or 324 mg subcutaneous) died." . rdfs:ABSTRACT-UID rdfs:label "6yhgtgzz" . rdfs:TRIPLE-UID rdfs:label "6yhgtgzz-TRIPLE-ABSTRACT-1" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }